𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer

✍ Scribed by Mary A. Bewick; Robert M. Lafrenie; Michael S. C. Conlon

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
199 KB
Volume
137
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Nucleotide excision repair polymorphisms
Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists
✍ Preetha Rajaraman; Parveen Bhatti; Michele Morin Doody; Steven L. Simon; Robert πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 85 KB πŸ‘ 1 views

## Abstract Exposure to ionizing radiation has been consistently associated with increased risk of female breast cancer. Although the majority of DNA damage caused by ionizing radiation is corrected by the base‐excision repair pathway, certain types of multiple‐base damage can only be repaired thro

Survival of patients with metastatic bre
Survival of patients with metastatic breast cancer diagnosed between 1955 and 1980
✍ Daniel Debonis; Jose J. Terz; Samuel Eldar; L. Robert Hill πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 522 KB

## Abstract In order to determine whether current programs for the management of metastatic breast cancer have led to improved patient survival, we determined the median survival times for five‐year intervals of 849 patients admitted to the City of Hope National Medical Center with metastatic breas

Circulating interleukin-6 predicts survi
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
✍ Roberto Salgado; Sara Junius; Ina Benoy; Peter Van Dam; Peter Vermeulen; Eric Va πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 1 views

## Abstract Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells, B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by upregulating anti‐apoptotic and angiogenic proteins in tumour cells. In murine models it has been demonstra